Traditional Dietary Advice Vs. Mediterranean Diet in IBS
A Randomized Trial of Traditional Dietary Advice Versus Mediterranean Diet in Irritable Bowel Syndrome
1 other identifier
interventional
139
1 country
1
Brief Summary
Irritable bowel syndrome (IBS) affects 5-10% of the population, and incurs substantial health impairment and healthcare utilization. Over 80% of individuals with IBS report food to trigger or aggravate symptoms, with many seeking to undertake dietary modifications. Current guidelines recommend first-line therapy with the relatively straightforward traditional dietary advice, with the more complex and restrictive low FODMAP diet reserved as second-line therapy. There is emerging data suggesting that the Mediterranean diet may also improve the symptoms of IBS, although it has not yet been subject to any head-to-head randomized dietary trials to help position it within the treatment algorithm. Given the relative ease of implementing the Mediterranean diet, alongside its recognized cardio-metabolic and mental health benefits, studying its efficacy in IBS is attractive as it could potentially pave the way for another first-line dietary option being available to patients before escalating to the demanding and resource intensive second-line therapies. The investigators will perform a randomized trial comparing the clinical efficacy of traditional dietary advice vs. a Mediterranean diet in IBS. Following dietary randomization, participants will complete validated questionnaires to assess changes in IBS symptoms, quality of life, mood, somatic symptoms, nutritional status, as well as dietary satisfaction and adherence.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Sep 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 25, 2023
CompletedFirst Posted
Study publicly available on registry
August 9, 2023
CompletedStudy Start
First participant enrolled
September 30, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 20, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 20, 2024
CompletedMarch 14, 2025
March 1, 2025
1.2 years
July 25, 2023
March 11, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of IBS patients experiencing clinical response with traditional dietary advice vs. Mediterranean diet
IBS symptom severity scale (IBS-SSS) where a 50-point reduction denotes a meaningful clinical response
Baseline to Week 6
Secondary Outcomes (7)
Changes in individual items of the IBS-SSS
Baseline to Week 6
Changes in Anxiety and Depression
Baseline to Week 6
Changes in Somatic Symptom reporting
Baseline to Week 6
Changes in quality of life
Baseline to Week 6
Dietary satisfaction to assigned intervention
Week 6
- +2 more secondary outcomes
Study Arms (2)
Traditional Dietary Advice
ACTIVE COMPARATORIts main elements are to adopt sensible eating habits and avoid excess fatty foods, spicy foods, processed foods, caffeine, fizzy drinks and alcohol.
Mediterranean Diet
ACTIVE COMPARATORThe principle components is a diet rich in vegetables, pulses, whole grains, and olive oil
Interventions
Eligibility Criteria
You may qualify if:
- IBS Symptom Severity Scale(IBS-SSS) \> 75
- Online access
- English literate
You may not qualify if:
- Organic gastrointestinal diseases (e.g. inflammatory bowel disease, GI cancer, coeliac disease, microscopic colitis, bile acid diarrhoea)
- Major abdominal surgery (except laparoscopy, appendectomy, cholecystectomy)
- History of eating disorder
- Body mass index \<20
- Current dietary interventions
- Current use of opioids/antibiotics
- Titrating dose of neuromodulators
- Severe systemic disease (e.g. cardiac, renal, respiratory, psychiatric) necessitating frequent medical consultations/hospitilisations
- Pregnant
- Diabetes mellitus
- Scleroderma
- Memory impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Royal Hallamshire Hospital
Sheffield, South Yorkshire, S10 2JF, United Kingdom
Related Publications (1)
Bamidele JO, Brownlow GM, Flack RM, Buckle RL, Shaw CC, Shiha MG, Aziz I. The Mediterranean Diet for Irritable Bowel Syndrome : A Randomized Clinical Trial. Ann Intern Med. 2025 Dec;178(12):1709-1717. doi: 10.7326/ANNALS-25-01519. Epub 2025 Oct 28.
PMID: 41144975DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Imran Aziz
Sheffield Teaching Hospitals NHS Foundation Trust
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 25, 2023
First Posted
August 9, 2023
Study Start
September 30, 2023
Primary Completion
December 20, 2024
Study Completion
December 20, 2024
Last Updated
March 14, 2025
Record last verified: 2025-03
Data Sharing
- IPD Sharing
- Will not share